The healthcare industry has been a top priority of U.S. antitrust enforcers in the past decade, with a high proportion of healthcare mergers and business practices subject to investigation and challenge by antitrust officials at the FTC and DOJ. The focus on healthcare is perhaps not surprising: healthcare costs are high and rising, and President Obama made healthcare reform a top priority of his administration. Republican administrations historically have taken a less interventionist approach to antitrust enforcement, raising speculation about whether the new administration will lessen antitrust scrutiny of the healthcare industry.
Join Maria Raptis, a partner in the Antitrust and Competition Group of Skadden, Arps, Slate, Meagher & Flom, LLP, as she reviews recent antitrust enforcement activity in healthcare, explains why antitrust scrutiny of the healthcare industry will
Maria A. Raptis represents clients in connection with the antitrust aspects of litigation, mergers and acquisitions, counseling and criminal matters.
Ms. Raptis has represented clients before the Federal Trade Commission and Department of Justice in numerous M&As, including SanDisk in its acquisition by Western Digital, Actavis in its acquisitions of Forest Laboratories and Warner Chilcott; Hewlett Packard in its acquisition of Samsung’s printing business; Gilead in its acquisition of Pharmasett; Valeant in its acquisitions of Salix, Medicis, Dermik, Ortho Dermatologics and Biovail; Rite Aid in its acquisition of Envision Pharmaceutical Services; NDS Group in its acquisition by Cisco Systems; Watson in its acquisitions of Actavis and Andrx; and StorageTek in its acquisition by Sun Microsystems.
Ms. Raptis’ litigation experience includes defending Actavis in suits brought by the FTC and private plaintiffs relating to "reverse payment" settlements for Androgel, representing Bausch & Lomb in connection with litigation challenging its pricing policies relating to disposable contact lenses, representing Actavis in a multidistrict litigation relating to patent settlements for Lidoderm and defending De Beers in connection with national class actions involving gem diamonds.
Ms. Raptis also has represented clients in connection with allegations of price-fixing or other criminal charges, including De Beers in connection with the resolution of a criminal matter relating to industrial diamonds.
Great presentation. Hot topics slides were appreciated.
liked how she navigated the political environment without fear.
I was engaged with the presenter in this material. She did a great job.
Instructor was knowledgeable; organized and had a style that I could follow. Very focused too!
very informative and good presentation overall
Unlimited CLE Subscription gives you access to take almost any course from our catalog and earn as much CLE credit as you need.